Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager

Arch Biopartners Inc

XTSX:ARCH

Watchlist

Dividends

Discount Rate

Price: 1.96 CAD 1.03%

Market Cap: 126.7m CAD

Have any thoughts about
Arch Biopartners Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 1.96 CAD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ARCH Alert

Arch Biopartners Inc

1.96

+0.02 (+1.03%)

52 Week Range	1.12 2.49
Price Target

We'll email you a reminder when the closing price reaches CAD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Arch Biopartners Inc

What unique competitive advantages
does Arch Biopartners Inc hold over its rivals?

What risks and challenges
does Arch Biopartners Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Arch Biopartners Inc.

What unique competitive advantages
does Arch Biopartners Inc hold over its rivals?

What risks and challenges
does Arch Biopartners Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Arch Biopartners Inc.

Provide P/S
for Arch Biopartners Inc.

Provide P/E
for Arch Biopartners Inc.

Provide P/OCF
for Arch Biopartners Inc.

Provide P/FCFE
for Arch Biopartners Inc.

Provide P/B
for Arch Biopartners Inc.

Provide EV/S
for Arch Biopartners Inc.

Provide EV/GP
for Arch Biopartners Inc.

Provide EV/EBITDA
for Arch Biopartners Inc.

Provide EV/EBIT
for Arch Biopartners Inc.

Provide EV/OCF
for Arch Biopartners Inc.

Provide EV/FCFF
for Arch Biopartners Inc.

Provide EV/IC
for Arch Biopartners Inc.

Show me price targets
for Arch Biopartners Inc made by professional analysts.

What are the Revenue projections
for Arch Biopartners Inc?

How accurate were the past Revenue estimates
for Arch Biopartners Inc?

What are the Net Income projections
for Arch Biopartners Inc?

How accurate were the past Net Income estimates
for Arch Biopartners Inc?

What are the EPS projections
for Arch Biopartners Inc?

How accurate were the past EPS estimates
for Arch Biopartners Inc?

What are the EBIT projections
for Arch Biopartners Inc?

How accurate were the past EBIT estimates
for Arch Biopartners Inc?

Compare the revenue forecasts
for Arch Biopartners Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Arch Biopartners Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Arch Biopartners Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Arch Biopartners Inc compared to its peers.

Compare the P/E ratios
of Arch Biopartners Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Arch Biopartners Inc with its peers.

Analyze the financial leverage
of Arch Biopartners Inc compared to its main competitors.

Show all profitability ratios
for Arch Biopartners Inc.

Provide ROE
for Arch Biopartners Inc.

Provide ROA
for Arch Biopartners Inc.

Provide ROIC
for Arch Biopartners Inc.

Provide ROCE
for Arch Biopartners Inc.

Provide Gross Margin
for Arch Biopartners Inc.

Provide Operating Margin
for Arch Biopartners Inc.

Provide Net Margin
for Arch Biopartners Inc.

Provide FCF Margin
for Arch Biopartners Inc.

Show all solvency ratios
for Arch Biopartners Inc.

Provide D/E Ratio
for Arch Biopartners Inc.

Provide D/A Ratio
for Arch Biopartners Inc.

Provide Interest Coverage Ratio
for Arch Biopartners Inc.

Provide Altman Z-Score Ratio
for Arch Biopartners Inc.

Provide Quick Ratio
for Arch Biopartners Inc.

Provide Current Ratio
for Arch Biopartners Inc.

Provide Cash Ratio
for Arch Biopartners Inc.

What is the historical Revenue growth
over the last 5 years for Arch Biopartners Inc?

What is the historical Net Income growth
over the last 5 years for Arch Biopartners Inc?

What is the current Free Cash Flow
of Arch Biopartners Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Arch Biopartners Inc.

Section:

Wall Street
Price Targets

ARCH Price Targets Summary
Arch Biopartners Inc

Wall Street analysts forecast ARCH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARCH is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

ARCH Average Forecast

Wall Street Target

3.57 CAD

82% Upside

ARCH Highest Forecast

Wall Street Target

3.68 CAD

88% Upside

Lowest

Price Target

3.54 CAD

80% Upside

Average

Price Target

3.57 CAD

82% Upside

Highest

Price Target

3.68 CAD

88% Upside

Arch Biopartners Inc Competitors:
Price Targets

237690

ST Pharm Co Ltd

50% Upside

ABCL

Abcellera Biologics Inc

332% Upside

DIVISLAB

Divi's Laboratories Ltd

11% Downside

TECN

Tecan Group AG

38% Upside

237690

ST Pharm Co Ltd

50% Upside

ABCL

Abcellera Biologics Inc

332% Upside

DIVISLAB

Divi's Laboratories Ltd

11% Downside

TECN

Tecan Group AG

38% Upside

MCAP

MedCap AB (publ)

1% Upside

PIQ

Proteomics International Laboratories Ltd

24% Downside

TMO

Thermo Fisher Scientific Inc

28% Upside

LONN

Lonza Group AG

18% Upside

Revenue
Forecast

Revenue Estimate
Arch Biopartners Inc

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Arch Biopartners Inc

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Arch Biopartners Inc

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

What is ARCH's stock price target?

Price Target
3.57 CAD

According to Wall Street analysts, the average 1-year price target for ARCH is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

Arch Biopartners Inc
XTSX:ARCH

Wall Street
Price Targets

ARCH Price Targets Summary
Arch Biopartners Inc

Revenue
Forecast

Revenue Estimate
Arch Biopartners Inc

Operating Income
Forecast

Operating Income Estimate
Arch Biopartners Inc

Net Income
Forecast

Net Income Estimate
Arch Biopartners Inc

See Also

What is ARCH's stock price target?

Price Target
3.57 CAD

Company

Help

Tools

Stocks

Arch Biopartners Inc XTSX:ARCH

Wall Street Price Targets

ARCH Price Targets Summary Arch Biopartners Inc

Revenue Forecast

Revenue Estimate Arch Biopartners Inc

Operating Income Forecast

Operating Income Estimate Arch Biopartners Inc

Net Income Forecast

Net Income Estimate Arch Biopartners Inc

See Also

What is ARCH's stock price target? Price Target 3.57 CAD

Company

Help

Tools

Stocks

Arch Biopartners Inc
XTSX:ARCH

Wall Street
Price Targets

ARCH Price Targets Summary
Arch Biopartners Inc

Revenue
Forecast

Revenue Estimate
Arch Biopartners Inc

Operating Income
Forecast

Operating Income Estimate
Arch Biopartners Inc

Net Income
Forecast

Net Income Estimate
Arch Biopartners Inc

What is ARCH's stock price target?

Price Target
3.57 CAD